Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-001008

Director sold 5,000 shares at an average $48.12 ($240,594)

From the SEC's structured data for this filing

Trades in this filing

Kelley Kenneth J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Sale : show line 1 in the form −4,754 $48.09 $228,617 190,079 D
2021-02-01 Sale : show line 2 in the form −246 $48.69 $11,977 189,833 D
Open-market sales · 5,000 sh · avg $48.12 · $240,594
Loading xslF345X03/edgar.xml…